Osteoarthritis Trial, Recruiting NCT07416357 Sponsor: Izmir Democracy University Condition: Osteoarthritis
Back to Osteoarthritis

Osteoarthritis Trial, Recruiting

NCT07416357
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are 45 years of age or older
  • You have been diagnosed with knee osteoarthritis (wear-and-tear of the knee joint), either through a doctor's examination or an X-ray
  • Your condition allows you to have an ultrasound scan performed on both knees
  • You are able to sign a written consent form agreeing to take part in the study
  • You are able to read and understand forms and questionnaires written in Turkish

Who may not be able to join:

  • You have been diagnosed with an inflammatory joint condition such as rheumatoid arthritis, psoriatic arthritis, gout, or a similar disease
  • You have had an injection directly into your knee joint (such as a steroid, hyaluronic acid, or PRP injection) within the last 6 months
  • You have previously had major knee surgery, such as a full knee replacement or major ligament reconstruction
  • You have had an acute knee injury, fracture, or ligament damage within the last 6 weeks
  • You have severe knee deformity or very limited knee movement that would make an ultrasound scan technically impossible
  • You currently have an active infection or a condition causing a fever
  • You have a neurological condition that causes weakness or loss of sensation in your legs
  • You currently take gabapentinoids, SNRIs, or SSRIs (certain medications used for fibromyalgia or mental health conditions) (confirm with trial site)
  • You have severe memory, thinking, or communication difficulties that would prevent you from taking part
  • You are currently pregnant
  • You have been told about the study and have chosen not to take part

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 5 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +905054529231

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Izmir Democracy University
Registry
ClinicalTrials.gov
Start date
1 February 2026
Est. completion
1 March 2027

Where this trial is recruiting

Turkey (Türkiye)

Primary endpoints

Western Ontario and McMaster Universities (WOMAC) score; Outcome Measures in Rheumatology knee osteoarthritis scale

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 5 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov